Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

9.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.9K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.6K
3.6K
RNA Splicing01:32

RNA Splicing

60.6K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.6K
Ribosomal RNA Synthesis02:53

Ribosomal RNA Synthesis

14.8K
Ribosome synthesis is a highly complex and coordinated process involving more than 200 assembly factors. The synthesis and processing of ribosomal components occurs not only in the nucleolus but also in the nucleoplasm and the cytoplasm of eukaryotic cells.
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
14.8K
Nursing Code of Ethics01:29

Nursing Code of Ethics

4.5K
The Nursing Code of Ethics sets the ethical benchmark for the profession, and guides nurses in ethical analysis and decision making at the societal, organizational, and clinical levels. The code encompasses showing compassion and respect for the patient, their families, and communities in all circumstances while committing to providing patient-centered care. In addition, the code states that nurses must advocate for the patient by defending a cause or recommendation to protect their rights,...
4.5K
Transfer RNA Synthesis02:36

Transfer RNA Synthesis

13.3K
One of the unique features of tRNA is the presence of modified bases. In some tRNAs, modified bases account for nearly 20% of the total bases in the molecule. Altogether, these unusual bases protect the tRNA from enzymatic degradation by RNases.
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
13.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of the Dedicator of Cytokinesis 2 (DOCK2) Gene Polymorphisms with COVID-19 and Plasma LDH, AST, ALT, and Ferritin Levels.

Biomolecules·2026
Same author

The Functional <i>OAS1</i> rs10774671A>G Variant Is Associated with COVID-19 Susceptibility in Mexican Patients.

International journal of molecular sciences·2026
Same author

Spatial Distribution of Organochlorine Pesticide Serum Concentrations in Mexican Children and Adolescents Living in and Out the Polluted Atoyac Watershed Basin.

GeoHealth·2026
Same author

Childhood cancer: an equity test for global health.

Lancet (London, England)·2026
Same author

Low-Intensity CD66c Expression Orchestrates an Immunosuppressive Niche Promoting Residual Disease in Pediatric ProB Acute Lymphoblastic Leukemia.

Cells·2026
Same author

Ancestry and somatic profile indicate acral melanoma origin and prognosis.

Nature·2026

Related Experiment Video

Updated: Jan 29, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

683

Long Non-Coding RNA and Acute Leukemia.

Gabriela Marisol Cruz-Miranda1, Alfredo Hidalgo-Miranda2, Diego Alberto Bárcenas-López3

  • 1Programa de Doctorado, Posgrado en Ciencias Biológicas, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico. gmcm611@hotmail.com.

International Journal of Molecular Sciences
|February 13, 2019
PubMed
Summary

Long non-coding RNAs (lncRNAs) are increasingly recognized for their role in childhood acute leukemia (AL) development and progression. This review explores lncRNAs as potential diagnostic biomarkers and therapeutic targets for AL.

Keywords:
acute leukemiacancerlong non-coding RNAstherapeutic targets

More Related Videos

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA
09:36

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA

Published on: April 10, 2018

26.3K
Identification of Coding and Non-coding RNA Classes Expressed in Swine Whole Blood
09:40

Identification of Coding and Non-coding RNA Classes Expressed in Swine Whole Blood

Published on: November 28, 2018

7.8K

Related Experiment Videos

Last Updated: Jan 29, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

683
RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA
09:36

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA

Published on: April 10, 2018

26.3K
Identification of Coding and Non-coding RNA Classes Expressed in Swine Whole Blood
09:40

Identification of Coding and Non-coding RNA Classes Expressed in Swine Whole Blood

Published on: November 28, 2018

7.8K

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Childhood acute leukemia (AL) is a significant global health concern, particularly in developing nations, with largely unknown etiological factors.
  • Long non-coding RNAs (lncRNAs) have emerged as critical players in the development and progression of hematological malignancies over the past decade.
  • Emerging evidence suggests lncRNAs' potential utility as biomarkers for leukemia diagnosis, prognosis, and predicting treatment response.

Purpose of the Study:

  • To review the functional classification and biogenesis of lncRNAs.
  • To elucidate the role of lncRNAs in leukemogenesis.
  • To summarize current evidence on lncRNAs implicated in acute leukemia and their potential as therapeutic targets.

Main Methods:

  • Comprehensive literature review of studies investigating lncRNAs in acute leukemia.
  • Analysis of functional classification, biogenesis pathways, and roles in leukemogenesis.
  • Synthesis of evidence regarding lncRNAs as diagnostic, prognostic, and therapeutic markers.

Main Results:

  • lncRNAs are involved in various stages of leukemogenesis, influencing cellular processes critical to leukemia development.
  • Specific lncRNAs have demonstrated potential as biomarkers for acute leukemia diagnosis and prognosis.
  • lncRNAs represent promising novel targets for developing targeted therapies against acute leukemia.

Conclusions:

  • lncRNAs play a multifaceted role in the pathophysiology of acute leukemia.
  • Further research into lncRNAs could lead to improved diagnostic tools and effective therapeutic strategies for childhood leukemia.
  • Targeting lncRNAs offers a promising avenue for future acute leukemia treatments.